Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels |
---|---|---|---|
1 | |||
Dysgeusia | x | ||
Rash | x | ||
Eye infection | x | ||
Eye penetration | x | ||
Headache | x | ||
Hypersensitivity | x | ||
Mydriasis | x | ||
Pruritus | x | ||
Urticaria | x | ||
Nerve injury | x | ||
Intraocular pressure increased | x | ||
Eye irritation | x | ||
Corneal perforation | x | ||
Vision blurred | x | ||
Visual disturbance | x | ||
Posterior subcapsular cataract | x | ||
Corneal thinning | x |
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | ||
---|---|---|---|
Inflammation | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |